Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

Multiple myeloma (MM) is a challenging hematological cancer which typically grows in bone marrow. MM accounts for 10% of hematological malignancies and 1.8% of cancers. The recent treatment strategies have significantly improved progression-free survival for MM patients in the last decade; however,...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Weam Othman Elbezanti, Kishore B. Challagundla, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2023-03-01
Serie:	Pharmaceuticals
Ämnen:	multiple myeloma B-cell malignancy bone marrow microenvironment drug resistance proteasome inhibitors immunotherapies
Länkar:	https://www.mdpi.com/1424-8247/16/3/415
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!